Skip to content

Sodium-Lactate and Traumatic Brain Injury

Sodium-Lactate Versus Mannitol in the Treatment of Intracranial Hypertensive Episodes in Severe Traumatic Brain Injured Patients

Status
Terminated
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00319345
Enrollment
34
Registered
2006-04-27
Start date
2003-11-30
Completion date
2005-11-30
Last updated
2010-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Hypertension, Severe Trauma Brain Injury

Keywords

Traumatic brain injury, Intracranial pressure, Osmotherapy, Glasgow outcome score, Mannitol, Sodium-Lactate

Brief summary

The purpose of this study is to compare the effect of bolus of either sodium-lactate or mannitol on the evolution of intracranial pressure (ICP) during intracranial hypertensive episodes (IHE)

Detailed description

Osmotherapy with mannitol remains the first treatment currently recommended to treat intracranial hypertension in severe head injury.However, this treatment in not always efficient and is associated with side-effects and a transitory action. Hypertonic sodium-lactate, by its osmotic and energetic properties could be superior to mannitol to decrease ICP. Study objectives : to compare the effect of mannitol and sodium-lactate on ICP at the fourth hour after the start of infusion during IHE in severe traumatic brain injury (TBI) (main endpoint) ; to compare the percentage of successfully treated episodes between both treatments and to compare the neurological status after one year of evolution (glasgow outcome score)(secondary endpoints) Patients inclusion : adult severe TBI (glasgow coma score \< 9) \< 66 yrs Exclusion criteria : polytrauma, bilateral fixed dilated pupils, motor score \< 4, neurosurgery, prolonged episode of hypoxia or arterial hypotension, 34 patients included from november 2003 to november 2004 and randomized into two groups : MAN group receiving mannitol 20% 100 ml in 15 min (17 patients, 36 episodes of IHE treated) and LAC group receiving semimolar sodium-lactate 100 ml in 15 min (17 patients, 37 episodes of IHE treated). For ethical reasons a rescue treatment in a crossover fashion was performed for each episode of IHE when the randomized treatment failed. Follow-up : one year after the TBI. Study end : november 30, 2005

Interventions

DRUGMannitol, Sodium-Lactate

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
CollaboratorOTHER_GOV
PT Kalbe Farma Tbk
CollaboratorINDUSTRY
Institut d'Anesthesiologie des Alpes Maritimes
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* age between 18 and 65 years * severe traumatic brain injury * prehospital glasgow coma scale \< 9 * rapid neurological worsening before admission

Exclusion criteria

* neurosurgical intervention * polytrauma * bilatéral fixed dilated pupils * motorscore \< 4 * prolonged episode of hypoxia or arterial hypotension * abundant rinorrhea

Design outcomes

Primary

MeasureTime frame
Efficiency to decrease ICP during IHE episodes

Secondary

MeasureTime frame
Number of successful treatment, neurological status (Glasgow outcome score) after one year of evolution

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026